Health
‘Significant humoral response’ following two COVID-19 vaccine doses in RMD patients – medwireNews
Most patients with rheumatic and musculoskeletal diseases mount a humoral immune response following receipt of the second dose…
medwireNews: Most patients with rheumatic and musculoskeletal diseases (RMDs) mount a humoral immune response following receipt of the second dose of the PfizerBioNTech (BNT162b2) vaccine against SARS-CoV-2, say researchers.
Yolanda Braun-Moscovici (Rambam…
Continue Reading
-
General15 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business15 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General16 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General18 hours agoAlbanese beats drum on economy as trade clouds gather